United States - 26th September
2019: Biochip Market size was valued at
USD 7.63 billion in 2015. With potential applications of genomics and
proteomics in biotech R&D, along with rapid technological innovation and
increase in adoption of personalized medicines, it is expected that this market
will witness considerable growth in revnue over the forecast period.
For biochip technology, in order to enhance its usability,
there is an improvement in resolution, preparation procedures and accuracy
along with the reduction in the cost of the materials associated with
manufacturing the biochips. These factors are expected to further reinforce
growth potential. Anticipated commercialization and launch of novel treatments
and diagnosis products including non-laboratory and laboratory research is
expected to fuel growth over the forecast period.
Request Sample Copy @
https://www.millioninsights.com/industry-reports/biochip-market-size/request-sample
Current developments aiming to miniaturize biochips even
further can be anticipated to increase the additional usage and applicability
for genetic sequencing methodologies, such as diabetes genomics. With the rise
in usage of the biochip technology, it is anticipated that cost of genome
profiling can reduce even further for studies such as protein expression
analysis among others. Hence, proteomics and genomics labeling techniques along
with other protein profiling techniques are expected to witness a growth in
demand.
Product Type Insights
DNA chips accounted for the largest share of revenue owing
to the presence of a considerable number of applications. Cancer
treatment/diagnostics has been observed to have major share for the usage of
biochips. Other segments contributing for the applications of biochips include
genotyping, agricultural biotechnology, genomic studies, single nucleotide
polymorphism and gene expression.
Biochip technology has the ability for miniaturizing
chemical & biological assays and molecular biology which provides a ground
for in-depth R&D of molecular biology at a minute level. Furthermore, the
ability of miniaturization is expected to improve even more and enhance the
efficiency in terms of inputs and cost requirements.
End-use Insights
Lab-on-a-chip, cell and tissue array, protein chips and DNA
chips find applications in biotechnology & pharmaceutical companies,
research & academic institutes, hospitals & diagnostics and point of
care settings which involves end users. Protein biochips and LOACs have found
widespread use for single nucleotide polymorphism genotyping, gene expression,
in vitro diagnosis, expression profiling, drug discovery, high throughput
screening and tissue arrays. The commercialization of the products in the development
pipelines of key market participants is also key towards the potential to drive
the growth for the market.
Sophisticated robotic tools are needed for scanning and
handling samples which are in micro-scale. Furthermore, for efficient data
analysis efficient bioinformatics system is required. Therefore, this will
increase the need for specific techniques and system which is expected to
increase the demand for biochips used in sophisticated machines. This will
consequently increase the price of the biochips and widen the offered product
range in the market.
Browse Complete
Report with TOC @ https://www.millioninsights.com/industry-reports/biochip-market-size
Biochip Outlook, by
End Use (Revenue, USD Million, 2013 - 2024)
•
Biotechnology and Pharmaceutical Companies
• Hospitals
and Diagnostics Centers
• Academic
& Research Institutes
• Others
For More Information,
Visit Our Blog @ www.digitalmarket360.wordpress.com
No comments:
Post a Comment